It may act as an oncogene and associated with the decreased overall survival, increase in the cancerous cells growth and cell proliferation by inhibiting CDKN2B in cancers such EC (Banaganapalli et al., 2020; Liu et al., 2018). The gene discussed is CDKN2B; the disease is cancer.